FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2186711000001105: Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25233501000001118 Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38030401000001112 Baxan 250mg/5ml oral suspension (Bristol-Myers Squibb Pharmaceuticals Ltd) 60 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Is a Cefadroxil 250mg/5ml oral suspension 60 ml true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Is pack of Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has active ingredient Cefadroxil monohydrate false Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has AMP Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefadroxil true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has specific active ingredient Cefadroxil monohydrate true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Baxan 250mg/5ml suspension (Bristol-Myers Squibb Pharmaceuticals Limited) 60 ml Has basis of strength substance Cefadroxil true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start